Document Classification

Section Type: RESULTS

Text: Grade higher than 0 (vinflunine v docetaxel) anemia (82. 1 % v 79. 8 %), neutropenia (49. 3 v 39. 02 %), thrombocytopenia (30. 6 % v 14. 3 %), febrile neutropenia (3. 3 % v 4. 7 %), constipation (39. 2 % v 11. 7 %), fatigue (36. 6 % v 33. 9 %), injection site reaction (31. 9 % v 0. 7 %), nausea (26. 7 % v 23. 7 %), vomiting (23. 8 % v 14. 2 %), alopecia (19. 8 % v 35. 4 %), stomatis (19. 4 % v 12. 4 %), abdominal pain (20. 1 % v 3. 6 %), myalgia (14. 7 % v 6. 6 %), peripheral neuropathy (10. 7 % v 15. 0 %), arthralgia (7. 0 % v 7. 7 %), diarrhea (6. 2 % v 12. 4 %), edema (1. 5 % v 5. 4 %), and nail disorders (1. 1 % v 5 ; 1 %) were observed.